Defilade Capital Management L.P. Purchases Shares of 213,027 Integer Holdings Corporation $ITGR

Defilade Capital Management L.P. acquired a new position in Integer Holdings Corporation (NYSE:ITGR) in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 213,027 shares of the medical equipment provider’s stock, valued at approximately $18,746,000. Integer makes up approximately 2.6% of Defilade Capital Management L.P.’s investment portfolio, making the stock its 19th largest holding. Defilade Capital Management L.P. owned about 0.63% of Integer as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently modified their holdings of ITGR. Vanguard Group Inc. lifted its stake in shares of Integer by 0.4% during the 4th quarter. Vanguard Group Inc. now owns 3,886,150 shares of the medical equipment provider’s stock valued at $304,791,000 after buying an additional 14,465 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in Integer by 6.5% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,484,396 shares of the medical equipment provider’s stock worth $130,620,000 after buying an additional 90,277 shares in the last quarter. State Street Corp raised its holdings in Integer by 3.7% during the fourth quarter. State Street Corp now owns 1,371,767 shares of the medical equipment provider’s stock valued at $107,588,000 after acquiring an additional 48,463 shares during the period. Viking Global Investors LP lifted its position in shares of Integer by 9.1% in the second quarter. Viking Global Investors LP now owns 1,283,965 shares of the medical equipment provider’s stock valued at $157,889,000 after acquiring an additional 106,692 shares in the last quarter. Finally, Irenic Capital Management LP bought a new position in shares of Integer in the fourth quarter worth about $99,109,000. 99.29% of the stock is currently owned by institutional investors.

Integer Trading Down 0.1%

Shares of ITGR stock opened at $121.07 on Monday. The company has a current ratio of 3.75, a quick ratio of 2.38 and a debt-to-equity ratio of 0.77. The stock has a market capitalization of $4.11 billion, a price-to-earnings ratio of 30.19, a price-to-earnings-growth ratio of 2.89 and a beta of 0.61. Integer Holdings Corporation has a 12-month low of $62.00 and a 12-month high of $123.50. The stock’s 50-day moving average price is $93.88 and its 200-day moving average price is $88.98.

Integer (NYSE:ITGR) last announced its quarterly earnings results on Thursday, April 30th. The medical equipment provider reported $1.20 EPS for the quarter, missing analysts’ consensus estimates of $1.21 by ($0.01). The firm had revenue of $439.58 million for the quarter, compared to the consensus estimate of $426.48 million. Integer had a net margin of 7.64% and a return on equity of 12.83%. Integer’s quarterly revenue was up .5% on a year-over-year basis. During the same period in the previous year, the company posted $1.31 earnings per share. Equities research analysts predict that Integer Holdings Corporation will post 6.04 EPS for the current fiscal year.

Analysts Set New Price Targets

Several analysts recently issued reports on ITGR shares. KeyCorp reissued an “overweight” rating and set a $104.00 target price on shares of Integer in a research note on Tuesday, July 21st. Freedom Capital upgraded Integer to a “strong-buy” rating in a research note on Wednesday, July 22nd. Truist Financial increased their price objective on shares of Integer from $97.00 to $110.00 and gave the company a “buy” rating in a report on Thursday, July 16th. HC Wainwright reiterated a “buy” rating on shares of Integer in a research report on Friday, July 24th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Integer in a report on Thursday, June 18th. One analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and seven have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $97.00.

Integer Company Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.